Welcome to Second Opinion’s permanent address. This is the Second Opinion blog — F&N Med’s content platform for growth-minded...
Second Opinion. Now on YouTube. The requests kept coming. More Second Opinion. More sharp takes on brand strategy for MedTech...
Build to the stage. Scale the story. Win big. Part VI in our “When to Invest In Brand” for growth-stage...
The Practical Reality: Brand Investment Is About Intelligent Sequencing. Part V in our “When to Invest In Brand” for growth-stage...
Introducing Second Opinion Sprints. MedTech leader that needs a take on brand, but is short on time? Introducing Second Opinion...
Why MedTech Companies Can’t Wait Past Series B To Build A Strategic Brand. Part IV in our “When to Invest...
The Series A–B Inflection: When Brand Becomes MedTech Infrastructure Part II in our “When to Invest In Brand” for growth-stage...
Part 2: Why Brand Strategy Needs to Start Earlier Than Most Founders Think (Late Seed to Early A) In early-stage...
When to Invest in Brand (And Why Timing Is Everything in MedTech) Part I: The quiet question shaping MedTech...